Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

In the News
Greg Scott presents industry update during JPMorgan
>> View video…

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

Tianyin Wins SFDA Approval for Antibiotic

publication date: Mar 17, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Tianyin Pharmaceutical, Co., Inc. continues the rapid pace of its news flow with an announcement that the SFDA approved the company’s generic form of antibiotic medicine Azithromycin Dispersible Tablets. For Tianyin, the approval was the first the company has received from the SFDA, and the drug will become the third Western-style drug in the portfolio. Most of Tianyin’s products are traditional Chinese medicines. To further diversify its product line, Tianyin has another 10 products awaiting SFDA approval. More details...

Stock Symbol: (OTCBB: TYNP) (NYSE: PFE)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events
April 14, 2010
Guangzhou, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
Suzhou, China
June 23-24, 2010
 
Partner Events

China 2010 Pharmaceutical R&D Summit
Shanghai, China
April 5-8, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners